{"schema_version":"secwatch.filing_event.v1","accession":"0000055529-25-000051","form_type":"8-K","ticker":"KEQU","cik":"0000055529","company_name":"KEWAUNEE SCIENTIFIC CORP /DE/","filed_at":"2025-12-10T23:59:59+00:00","discovered_at":"2026-05-14T18:02:41.866532+00:00","generated_at":"2026-05-16T13:42:41.044374+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Kewaunee Scientific Q2 FY2026: sales +46.8% to $70.1M, diluted EPS $0.82 vs $1.01","bullets":["Sales up 46.8% to $70.1M; net earnings $2.45M (-18.7%); diluted EPS $0.82 (vs $1.01).","Domestic sales $55.2M (+51.7%) driven by Nu Aire; segment earnings $3.6M (down from $4.5M).","International sales $14.9M (+31.0%) on large project deliveries; segment earnings $0.64M vs $0.36M.","Backlog $192.9M (near record); management reports strong quoting but expects delivery volatility.","Debt-to-equity improved to 0.88x; early repayment of Seller Notes strengthens balance sheet."],"urls":{"canonical":"https://secwatch.observer/filing/0000055529-25-000051","json":"https://secwatch.observer/filing/0000055529-25-000051.json","markdown":"https://secwatch.observer/filing/0000055529-25-000051.md","text":"https://secwatch.observer/filing/0000055529-25-000051.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/55529/000005552925000051/0000055529-25-000051-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/55529/000005552925000051/kequ-20251210.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T13:42:41.044374+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}